Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors

Oncogene

Volumn 24, Issue 16, 2005, Pages 2695-2704

  Klinger, Mark B ^a,b,c   Guilbault, Benoit ^a,b,d   Goulding, Rebecca E ^a,b   Kay, Robert J ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d StemCell Technologies Inc   (Canada)

Author keywords

Leukemia; Lymphoma; T lymphocytes; T cell receptors

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; HY ANTIGEN; PROTEIN RASGRP1; RAS PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE; THYMOCYTE; THYMUS LYMPHOMA; TRANSGENIC MOUSE;

ANIMALS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; LEUKEMIA; LYMPHOMA, T-CELL; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; TRANSGENES;

EID: 17844375168     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208334     Document Type: Article

References (37)

1. Adams JM, Harris AW, Strasser A, Ogilvy S and Cory S. (1999). Oncogene, 18, 5268-5277.
2. Ahuja HG, Foti A, Bar-Eli M and Cline MJ. (1990). Blood, 75, 1684-1690.
3. Anderson G, Hare KJ and Jenkinson EJ. (1999). Immunol. Today, 20, 463-468.
4. Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH, Davi F, Landman-Parker J, Quartier P, Buzyn A, Delabesse E, Valensi F and Macintyre E. (2002). Blood, 101, 2693-2703.
5. Azzam HS, Grinberg A, Lui K, Shen H, Shores EW and Love PE. (1998). J. Exp. Med., 188, 2301-2311.
6. Bivona TG, Perez De Castro I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ, Cullen PJ, Pellicer A, Cox AD and Philips MR. (2003). Nature, 29, 29.
7. Bruno L, Fehling HJ and von Boehmer H. (1996). Immunity, 5, 343-352.
8. Cleverley SC, Costello PS, Henning SW and Cantrell DA. (2000). Oncogene, 19, 13-20.
9. Curtis DJ, Robb L, Strasser A and Begley CG. (1997). Oncogene, 15, 2975-2983.
10. Dailey MO. (1998). Crit. Rev. Immunol., 18, 153-184.
11. Dower NA, Stang SL, Bottorff DA, Ebinu JO, Dickie P, Ostergaard HL and Stone JC. (2000). Nat. Immunol., 1, 317-321.
12. Dunbar CE, Crosier PS and Nienhuis AW. (1991). Oncogene Res., 6, 39-51.
13. Ebinu JO, Stang SL, Teixeira C, Bottorff DA, Hooton J, Blumberg PM, Barry M, Bleakley RC, Ostergaard HL and Stone JC. (2000). Blood, 95, 3199-3203.
14. Egerton M, Shortman K and Scollay R. (1990). Int. Immunol., 2, 501-507.
15. Erman B, Feigenbaum L, Coligan JE and Singer A. (2002). Nat. Immunol., 3, 564-569.
16. Hawley RG, Fong AZ, Ngan BY and Hawley TS. (1995). Oncogene, 11, 1113-1123.
17. Hogquist KA. (2001). Curr. Opin. Immunol., 13, 225-231.
18. Iritani BM, Alberola-Ila J, Forbush KA and Perimutter RM. (1999). Immunity, 10, 713-722.
19. Iritani BM, Forbush KA, Farrar MA and Perlmutter RM. (1997). EMBO J., 16, 7019-7031.
20. Kawamura M, Ohnishi H, Guo SX, Sheng XM, Minegishi M, Hanada R, Horibe K, Hongo T, Kaneko Y, Bessho F, Yanagisawa M, Sekiya T and Hayashi Y. (1999). Leuk. Res., 23, 115-126.
21. Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG and Lenz J. (2003). J. Virol., 77, 2056-2062.
22. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M and von Boehmer H. (1988). Nature, 333, 742-746.
23. Kruisbeek AM, Haks MC, Carleton M, Michie AM, Zuniga-Pflucker JC and Wiest DL. (2000). Immunol. Today, 21, 637-644.
24. Layer K, Lin G, Nencioni A, Hu W, Schmucker A, Antov AN, Li X, Takamatsu S, Chevassut T, Dower NA, Stang SL, Beier D, Buhlmann J, Bronson RT, Elkon KB, Stone JC, Van Parijs L and Lim B. (2003). Immunity, 19, 243-255.
25. Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T, Shaughnessy Jr JD, Jenkins NA and Copeland NG. (1999). Nat. Genet., 23, 348-353.
26. Michie AM and Zuniga-Pflucker JC. (2002). Semin. Immunol., 14, 311-323.
27. Norment AM, Bogatzki LY, Klinger M, Ojala EW, Bevan MJ and Kay RJ. (2003). J. Immunol., 170, 1141-1149.
28. Priatel JJ, Teh SJ, Dower NA, Stone JC and Teh HS. (2002). Immunity, 17, 617-627.
29. Quilliam LA, Rebhun JF and Castro AF. (2002). Prog. Nucleic Acid Res. Mol. Biol., 71, 391-444.
30. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF and Ohashi PS. (1999). Annu. Rev. Immunol., 17, 829-874.
31. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F and Stall AM. (1992). Cell, 68, 855-867.
32. Swat W, Shinkai Y, Cheng HL, Davidson L and Alt FW. (1996). Proce. Nat. Acad. Sci. USA, 93, 4683-4687.
33. Terrence K, Pavlovich CP, Matechak EO and Fowlkes BJ. (2000). J. Exp. Med., 192, 537-548.
34. Tiong Ong S, Ly C, Nguyen M, Kay Brightman B and Fan H. (2003). Cell Immunol., 221, 64-79.
35. Von Boehmer H, Aifantis I, Gounari F, Azogui O, Haughn L, Apostolou I, Jaeckel E, Grassi F and Klein L. (2003). Immunol. Rev., 191, 62-78.
36. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L and Downing JR. (2002). Cancer Cell, 1, 133-143.
37. Yokota S, Nakao M, Horiike S, Seriu T, Iwai T, Kaneko H, Azuma H, Oka T, Takeda T, Watanabe A, Kikuta A, Asami K, Sekine I, Matsushita T, Tsuhciya T, Mimaya J, Koizumi S, Miyake M, Nishikawa K, Takaue Y, Kawano Y, Iwai A, Ishida Y, Matsumoto K and Fujimoto T. (1998). Int J Hematol, 67, 379-387.